Cargando…
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies
[Image: see text] SETD2, a lysine N-methyltransferase, is a histone methyltransferase that plays an important role in various cellular processes and was identified as a target of interest in multiple myeloma that features a t(4,14) translocation. We recently reported the discovery of a novel small-m...
Autores principales: | Alford, Joshua S., Lampe, John W., Brach, Dorothy, Chesworth, Richard, Cosmopoulos, Kat, Duncan, Kenneth W., Eckley, Sean T., Kutok, Jeffrey L., Raimondi, Alejandra, Riera, Thomas V., Shook, Brian, Tang, Cuyue, Totman, Jennifer, Farrow, Neil A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290024/ https://www.ncbi.nlm.nih.gov/pubmed/35859865 http://dx.doi.org/10.1021/acsmedchemlett.2c00167 |
Ejemplares similares
-
Discovery of a First-in-Class Inhibitor of the Histone
Methyltransferase SETD2 Suitable for Preclinical Studies
por: Lampe, John W., et al.
Publicado: (2021) -
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals
por: Marafini, Irene, et al.
Publicado: (2019) -
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
por: Thomenius, Michael J., et al.
Publicado: (2018) -
P04.14. Acupuncture for carpal tunnel syndrome: a systematic review of randomized controlled trials
por: Shim, H, et al.
Publicado: (2012) -
Safety evaluation of the food enzyme endo‐1,3(4)‐β‐glucanase from the genetically modified Bacillus subtilis strain DP‐Ezm28
por: Silano, Vittorio, et al.
Publicado: (2021)